Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion- and chorion-derived mesenchymal stem cells

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Yamahara, Kenichi ^a   Harada, Kazuhiko ^a   Ohshima, Makiko ^a   Ishikane, Shin ^a   Ohnishi, Shunsuke ^b   Tsuda, Hidetoshi ^a   Otani, Kentaro ^a   Taguchi, Akihiko ^c   Soma, Toshihiro ^d   Ogawa, Hiroyasu ^d   Katsuragi, Shinji ^a   Yoshimatsu, Jun ^a   Harada Shiba, Mariko ^a   Kangawa, Kenji ^a   Ikeda, Tomoaki ^a,e  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

^e MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; PROSTAGLANDIN E2; SCATTER FACTOR; SOMATOMEDIN C RECEPTOR; VASCULOTROPIN;

ACUTE GRAFT VERSUS HOST DISEASE; AMNION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BLOOD FLOW; CAPILLARY DENSITY; CD4+ T LYMPHOCYTE; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CELL PROTECTION; CELL STRUCTURE; CELL SURFACE; CHORION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FETUS; FETUS MEMBRANE; HEART MUSCLE CELL; HINDLIMB; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOMODULATION; IN VITRO STUDY; LIMB ISCHEMIA; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT;

AMNION; ANIMALS; CHORION; CYTOPROTECTION; FEMALE; HINDLIMB; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOSUPPRESSION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISCHEMIA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 84895833456     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088319     Document Type: Article

References (22)

1. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74.
2. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295. (Pubitemid 35471185)
3. Ishikane S, Ohnishi S, Yamahara K, Sada M, Harada K, et al. (2008) Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells 26: 2625-2633.
4. Ishikane S, Yamahara K, Sada M, Harada K, Kodama M, et al. (2010) Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats. J Mol Cell Cardiol 49: 753-761.
5. Tsuda H, Yamahara K, Ishikane S, Otani K, Nakamura A, et al. (2010) Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis. Am J Physiol Renal Physiol 299: F1004-1013.
6. Ohshima M, Yamahara K, Ishikane S, Harada K, Tsuda H, et al. (2012) Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis. J Mol Cell Cardiol 53: 420-428.
7. Tsuda H, Yamahara K, Otani K, Okumi M, Yazawa K, et al. (2013) Transplantation of allogenic fetal membrane-derived mesenchymal stem cells protect against ischemia-reperfusion-induced acute kidney injury. Cell Transplant.
8. Ishikane S, Hosoda H, Yamahara K, Akitake Y, Kyoungsook J, et al. (2013) Allogeneic Transplantation of Fetal Membrane-Derived Mesenchymal Stem Cell Sheets Increases Neovascularization and Improves Cardiac Function after Myocardial Infarction in Rats. Transplantation.
9. Portmann-Lanz CB, Schoeberlein A, Huber A, Sager R, Malek A, et al. (2006) Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol 194: 664-673. (Pubitemid 43333137)
10. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317. (Pubitemid 44269669)
11. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, et al. (1995) Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 96: 1280-1287.
12. Yamahara K, Sone M, Itoh H, Yamashita JK, Yurugi-Kobayashi T, et al. (2008) Augmentation of neovascularization [corrected] in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells. PLoS One 3: e1666.
13. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822. (Pubitemid 40223708)
14. Kikuchi-Taura A, Taguchi A, Kanda T, Inoue T, Kasahara Y, et al. (2012) Human umbilical cord provides a significant source of unexpanded mesenchymal stromal cells. Cytotherapy 14: 441-450.
15. Wei JP, Zhang TS, Kawa S, Aizawa T, Ota M, et al. (2003) Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant 12: 545-552. (Pubitemid 36993198)
16. Pan HC, Yang DY, Chiu YT, Lai SZ, Wang YC, et al. (2006) Enhanced regeneration in injured sciatic nerve by human amniotic mesenchymal stem cell. J Clin Neurosci 13: 570-575.
17. Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, et al. (2004) Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78: 1439-1448. (Pubitemid 39552929)
18. Rossi D, Pianta S, Magatti M, Sedlmayr P, Parolini O (2012) Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity. PLoS One 7: e46956.
19. Kim SW, Zhang HZ, Guo L, Kim JM, Kim MH (2012) Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities. PLoS One 7: e41105.
20. Lee JM, Jung J, Lee HJ, Jeong SJ, Cho KJ, et al. (2012) Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int Immunopharmacol 13: 219-224.
21. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, et al. (2006) Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12: 459-465.
22. Gnecchi M, He H, Liang OD, Melo LG, Morello F, et al. (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11: 367-368. (Pubitemid 40562318)